pubmed-article:8845374 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8845374 | lifeskim:mentions | umls-concept:C0080298 | lld:lifeskim |
pubmed-article:8845374 | lifeskim:mentions | umls-concept:C0020792 | lld:lifeskim |
pubmed-article:8845374 | lifeskim:mentions | umls-concept:C0034802 | lld:lifeskim |
pubmed-article:8845374 | lifeskim:mentions | umls-concept:C0031715 | lld:lifeskim |
pubmed-article:8845374 | lifeskim:mentions | umls-concept:C0005456 | lld:lifeskim |
pubmed-article:8845374 | lifeskim:mentions | umls-concept:C1514562 | lld:lifeskim |
pubmed-article:8845374 | lifeskim:mentions | umls-concept:C1519063 | lld:lifeskim |
pubmed-article:8845374 | lifeskim:mentions | umls-concept:C1883221 | lld:lifeskim |
pubmed-article:8845374 | lifeskim:mentions | umls-concept:C1149348 | lld:lifeskim |
pubmed-article:8845374 | lifeskim:mentions | umls-concept:C0813988 | lld:lifeskim |
pubmed-article:8845374 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
pubmed-article:8845374 | lifeskim:mentions | umls-concept:C1883204 | lld:lifeskim |
pubmed-article:8845374 | lifeskim:mentions | umls-concept:C1880389 | lld:lifeskim |
pubmed-article:8845374 | pubmed:issue | 50 | lld:pubmed |
pubmed-article:8845374 | pubmed:dateCreated | 1996-10-22 | lld:pubmed |
pubmed-article:8845374 | pubmed:abstractText | During epidermal growth factor mediated signal transduction, intracellular receptor autophosphorylation on tyrosine residues results in the localization of several SH2 domain bearing proteins, including c-src, to the plasma membrane. This process is part of a complex pathway of specific protein associations that culminates in the regulation of cell growth and mitogenesis. The SH2 domain-mediated interaction of c-src with the EGF receptor has been demonstrated, yet the precise function of c-src in EGF receptor signaling remains unclear. The phosphorylation of EGFR by c-src was studied in order to evaluate the molecular basis for this interaction. The C-terminal autophosphorylation domain of EGFR was extensively phosphorylated by c-src and EGFR kinase activities in vitro as determined by electrospay ionization mass spectrometry. The sites of phosphorylation within the autophosphorylation domain (residues 976-1186) were identified by LC/MS, LC/MS/MS, and Edman sequencing. The majority of the sites identified corresponded to the known autophosphorylation sites of EGFR. Kinetic analyses of site-specific phosphorylation were made combining very fast enzyme digests (< = or 2 min) and high-speed, perfusion chromatography. These studies revealed that Y1086 was phosphorylated to a significantly higher extent by c-src than by EGFR. Additionally, Y1101 was identified as a unique c-src phosphorylation site. The function of these phosphorylation sites with respect SH2 domain interactions was investigated by affinity chromatography/mass spectrometry. A subset of peptides corresponding to the eight possible tyrosine phosphorylation sites within the EGFR autophosphorylation domain was demonstrated to bind to the SH2 domain of c-src. Those which bound to the SH2 domain included peptides derived from EGFR sequences flanking Y992, Y1086, Y1101, and Y1148. These data indicate that specific EGF receptor c-src phosphorylation sites are also ligands for the SH2 domain of c-src. Finally, extensive c-src phosphorylation of EGFR promoted its conversion to a form that exhibits high-affinity (KD = 380 nM) and cooperative (Hill coefficient; n = 2) binding to the SH2 domain of c-src as measured by surface plasmon resonance. The identification of c-src phosphorylation sequences on EGFR as c-src SH2 binding sites supports the notion that this interaction plays a significant role in the regulation of growth factor receptor function and signal transduction. | lld:pubmed |
pubmed-article:8845374 | pubmed:language | eng | lld:pubmed |
pubmed-article:8845374 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8845374 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8845374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8845374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8845374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8845374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8845374 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8845374 | pubmed:month | Dec | lld:pubmed |
pubmed-article:8845374 | pubmed:issn | 0006-2960 | lld:pubmed |
pubmed-article:8845374 | pubmed:author | pubmed-author:LombardoC RCR | lld:pubmed |
pubmed-article:8845374 | pubmed:author | pubmed-author:KasselD BDB | lld:pubmed |
pubmed-article:8845374 | pubmed:author | pubmed-author:ConslerT GTG | lld:pubmed |
pubmed-article:8845374 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8845374 | pubmed:day | 19 | lld:pubmed |
pubmed-article:8845374 | pubmed:volume | 34 | lld:pubmed |
pubmed-article:8845374 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8845374 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8845374 | pubmed:pagination | 16456-66 | lld:pubmed |
pubmed-article:8845374 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:8845374 | pubmed:meshHeading | pubmed-meshheading:8845374-... | lld:pubmed |
pubmed-article:8845374 | pubmed:meshHeading | pubmed-meshheading:8845374-... | lld:pubmed |
pubmed-article:8845374 | pubmed:meshHeading | pubmed-meshheading:8845374-... | lld:pubmed |
pubmed-article:8845374 | pubmed:meshHeading | pubmed-meshheading:8845374-... | lld:pubmed |
pubmed-article:8845374 | pubmed:meshHeading | pubmed-meshheading:8845374-... | lld:pubmed |
pubmed-article:8845374 | pubmed:meshHeading | pubmed-meshheading:8845374-... | lld:pubmed |
pubmed-article:8845374 | pubmed:meshHeading | pubmed-meshheading:8845374-... | lld:pubmed |
pubmed-article:8845374 | pubmed:meshHeading | pubmed-meshheading:8845374-... | lld:pubmed |
pubmed-article:8845374 | pubmed:meshHeading | pubmed-meshheading:8845374-... | lld:pubmed |
pubmed-article:8845374 | pubmed:meshHeading | pubmed-meshheading:8845374-... | lld:pubmed |
pubmed-article:8845374 | pubmed:meshHeading | pubmed-meshheading:8845374-... | lld:pubmed |
pubmed-article:8845374 | pubmed:meshHeading | pubmed-meshheading:8845374-... | lld:pubmed |
pubmed-article:8845374 | pubmed:meshHeading | pubmed-meshheading:8845374-... | lld:pubmed |
pubmed-article:8845374 | pubmed:year | 1995 | lld:pubmed |
pubmed-article:8845374 | pubmed:articleTitle | In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites. | lld:pubmed |
pubmed-article:8845374 | pubmed:affiliation | Department of Protein Biochemistry, Glaxo Wellcome, Inc., Research Triangle Park, North Carolina 27709, USA. | lld:pubmed |
pubmed-article:8845374 | pubmed:publicationType | Journal Article | lld:pubmed |
entrez-gene:1950 | entrezgene:pubmed | pubmed-article:8845374 | lld:entrezgene |
entrez-gene:1956 | entrezgene:pubmed | pubmed-article:8845374 | lld:entrezgene |
entrez-gene:6714 | entrezgene:pubmed | pubmed-article:8845374 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:8845374 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:8845374 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8845374 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8845374 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8845374 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8845374 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8845374 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8845374 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8845374 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8845374 | lld:pubmed |